TechyBird Acquisition Corp., a special-purpose acquisition company, has filed for an initial public offering (IPO) with the Securities and Exchange Commission. The company's focus is on pursuing a business combination in the biotechnology and pharmaceutical sectors, specifically targeting growth companies with enterprise values ranging from $100 million to $2 billion.
IPO Details
TechyBird plans to offer 6 million units at a price of $10 per unit. Each unit will include one ordinary share and the right to receive one-fifth of an ordinary share after the initial business merger is completed. The company expects its shares to be traded on the Nasdaq Global Market under the ticker symbol TKBD.
Use of Proceeds
The majority of the proceeds from the offering will be allocated to a trust account. The remaining funds will be used for legal and accounting fees, office space, working capital, and director and officer liability insurance.
Business Combination Timeline
TechyBird has set a one-year timeline from the closing of its offering to complete an initial business combination. However, the company has the option to extend this deadline by up to 12 months by depositing additional funds into its trust account.
Our Latest News
Swiss Watch Exports Show Normalization of Growth Trends
Swiss watch exports in 2023 show a normalization of growth trends, with strong performance in bimetallic watches and unexpected export growth to the U.S. catego...
TI Fluid Systems Announces Structural Changes to Drive Growth
TI Fluid Systems is implementing strategic changes to its organizational structure to remain customer-centric and adaptable in the electric vehicle market. The...
Shares of Banks and Financial Institutions Flat as Consumers Pull Back on Credit-Card Spending
Consumers cutting credit-card spending causes shares of banks to remain flat, raising concerns among investors. Treasury yields near multi-year high indicate ma...